BUSINESS DEVELOPMENT

The development of new molecules, drug delivery systems and medical devices is an expensive and risky business. The delay to recruit eligible patients undoubtedly has a negative financial impact in the compound development.

At INTRIALS we understand that time is money and therefore, we are always open to establish collaborative agreements with organizations worldwide, in order to help accelerate clinical development. We have an extensive history of successfully-concluded projects, several case studies and winning collaborations that have resulted in very satisfied clients.

Contact us to access a presentation about the region and to learn more about how INTRIALS can assist you conduct studies in Latin America.